Inside Precision Medicine
ctDNA Methylation Profiles Power Effective Colorectal Cancer Diagnosis, Prognosis, and Screening
![Epic Sciences said today its liquid biopsy blood test showed in a study that it can help physicians select prostate cancer patients who are likely to benefit from a Pfizer prostate-specific membrane antigen (PSMA)-targeted therapy candidate known as BIND-014 before the start of treatment. [Source: © Alex Tihonov/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1907.jpeg "LAM Gets FDA Breakthrough Designation for Liver Cancer Liquid Biopsy")
![GNS and Swedish Cancer Institute launch collaboration aimed at advancing the use of precision medicine in care for breast cancer patients. [Source: © Arto/Fotolia.com]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1243.jpeg "Methylation Implicated in Aspirin Benefit for Breast Cancer Patients")
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.
Terms of ServicePrivacy Policy
